Menu Back to Better-Medicines-for-Children

Overview

This conference will focus on two major developments currently affecting Paediatric Development: Innovative approaches to Drug Development and the impact of the current environment on the Regulatory and Research Infrastructure. You will gain critical insights from Regulators and leading industry experts about the latest scientific innovations and have the opportunity to engage in lively discussions with Paediatric Committee (PDCO) members and other industry experts involved in paediatric drug development. The patient experience will be voiced throughout the conference.

Featured topics

  • Leap in scientific innovation – how to address it for children
  • Future perspectives of the EU research landscape – IMI and beyond
  • Orphans and Paediatrics - where do we stand?

Who should attend?

  • Regulatory, clinical and drug development professionals from Health Authorities and Industry interested in paediatric drug development
  • Paediatricians, Representatives from Academia, Paediatric Societies and Networks, Patient Organisations
  • Employees from Clinical Research Organisations (CROs) involved in paediatric clinical trials
  • Any stakeholder interested in the development of better medicines for children

Learning objectives

  • Update participants on current paediatric regulatory requirements, scientific and operational successes and challenges
  • Provide overview of the way Brexit impacts Paediatric Development Strategy
  • Showcase latest developments with regards to innovation in how the paediatric studies are designed and conducted

Program Committee

  • Heidrun  Hildebrand
    Heidrun Hildebrand Global Program Head
    Bayer AG, Germany
  • Mette  Due Theilade Thomsen, PhD
    Mette Due Theilade Thomsen, PhD Managing Director
    PIP Adviser, Denmark
  • Geneviève  Le Visage, PharmD, MSc
    Geneviève Le Visage, PharmD, MSc Regional Head RA Europe Policy & Liaison
    Novartis Pharma AG, Switzerland
  • Dimitrios  Athanasiou, MBA
    Dimitrios Athanasiou, MBA Patient Advocate
    WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS, Greece
  • Martine  Dehlinger-Kremer, PhD
    Martine Dehlinger-Kremer, PhD Vice President, Pediatric Development
    Synteract, United States
  • Siri  Wang, PhD
    Siri Wang, PhD Scientific Director; PDCO Member
    Norwegian Medicines Agency, Norway
Load More

Contact us


Registration Questions?

Send Email
+41 61 225 51 51

 

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download